| 12024558 |
Method of inhibiting HIV-1 viral rebound in a subject using interferon inhibitors and ART |
— |
2024-07-02 |
| 11957748 |
Vaccine to pathogenic immune activation cells during infections |
— |
2024-04-16 |
| 11365392 |
Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cells and therapeutic uses thereof |
Helene Le Buanec, Sophie Duchez, Valerie Schiavon, Armand Bensussan |
2022-06-21 |
| 11198851 |
Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic uses thereof |
Helene Le Buanec, Sophie Duchez, Valerie Schiavon, Armand Bensussan |
2021-12-14 |
| 11077185 |
Vaccine to pathogenic immune activation cells during infections |
— |
2021-08-03 |
| 10632186 |
Vaccine to pathogenic immune activation cells during infections |
— |
2020-04-28 |
| 8697047 |
Stable immunogenic product comprising antigenic heterocomplexes |
Helene Le Buannec |
2014-04-15 |
| 8679483 |
High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
Bernard Bizzini, Helene Le Buanec |
2014-03-25 |
| 8372388 |
Method for preparing a stable TNF-α vaccine |
Helene Le Buanec |
2013-02-12 |
| 8101165 |
Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors |
Jean-Francois Zagury, Bernard Bizzini, Helene Le Buanec |
2012-01-24 |
| 7972603 |
Stable immunogenic product comprising antigenic heterocomplexes |
Helene Le Buannec |
2011-07-05 |
| 7887811 |
Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier protein |
Helene Le Buanec |
2011-02-15 |
| 7504479 |
Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses |
Jean-Francois Zagury |
2009-03-17 |
| 7351554 |
Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's |
— |
2008-04-01 |
| 7314629 |
Non-immunosuppressive immunogenic or vaccine composition comprising a mutated E7 protein of the HPV-16 virus |
Helene Le Buanec, Bernard Bizzini |
2008-01-01 |
| 7208148 |
Chemically modified cytokines |
Jean-Francois Zagury |
2007-04-24 |
| 7067246 |
Method for determining prognosis of HIV infected individuals |
Jean-Francois Zagury |
2006-06-27 |
| 7022482 |
Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses |
Jean-Francois Zagury |
2006-04-04 |
| 7015016 |
Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory IgA's |
— |
2006-03-21 |
| 6878370 |
Chemically modified TNF-α |
Jean-Francois Zagury |
2005-04-12 |
| 6455045 |
Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing them |
Jean-Francois Zagury, Bernard Bizzini |
2002-09-24 |
| 6228890 |
Use of alicyclic diamines as immunomodulators |
Jean-Claude Maziere, Amar Achour, Jean-Charles Landureau |
2001-05-08 |
| 6200575 |
Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them |
Jean-Francois Zagury, Bernard Bizzini |
2001-03-13 |
| 6132721 |
Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
Jean-Francois Zagury, Bernard Bizzini |
2000-10-17 |
| 6093405 |
Inactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokines |
Jean-Francois Zagury, Bernard Bizzini |
2000-07-25 |